(1)
Ferrandiz, C.; de la Cueva Dobao, P.; Simpson, E. L.; Zhang, R.; Gadkari, A.; Eckert, L.; Akinlade, B.; Ardeleanu, M. Dupilumab in Moderate-to-Severe Atopic Dermatitis: Pooled Efficacy Results from Two Identically Designed Randomized Phase 3 Trials (SOLO 1 & 2). J of Skin 2017, 1, s38.